Biotech

All Articles

ArsenalBio elevates $325M, rotates off of previous lead possession

.Collection Biosciences is actually going on up. The tissue treatment provider has actually added on...

Lilly- backed weight reduction biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana make use of drug fails period 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's hopes of securing a quick, good decision on a $100 thousand possibility payment have ...

ProKidney halts period 3 test certainly not needed to have for cell therapy approval

.ProKidney has actually ceased among a set of stage 3 tests for its own cell treatment for renal con...

Vaxcyte rises on 'spectacular' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what experts named "impressive" stage 1/2 data for its own 31-valent pneumococcal ...

Recursion's mind health condition test presents insufficient documentation of efficacy

.Recursion has discovered via a very early test of its own tech-enabled approach to medication revel...

Acepodia, Pfizer click with each other for chemistry-based tissue treatment

.Call it an instance of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winni...

Praxis epilepsy medication lowers seizures in period 2 hearing

.Praxis Accuracy Medicines has racked up one more midphase win in epilepsy this year, with its sodiu...

Three execs surrender as Dyne blog posts combined records for DMD applicant

.After running away a clinical hold many years back, Dyne Therapeutics has actually revealed brand-n...

Arrowhead fires off phase 3 data in uncommon metabolic condition before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own give in advance of a prospective showdown with Ioni...